Breadcrumb

[A18-85] Cabozantinib (hepatocellular carcinoma) - Benefit assessment according to §35a Social Code Book V

Overview

Overview

Commission: Commission awarded on 2018-12-11 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Executive summary of dossier assessment  [PDF, 96 kB] (German version) Further documents
Note:

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Contact address:to the contact form
Linked projects: [G19-11] Cabozantinib (hepatocellular carcinoma) - Second Addendum to Commission A18-85
Status: Commission completed

[G14-07] Cabozantinib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)
Status: Commission completed

[A19-38] Cabozantinib (hepatocellular carcinoma) - Addendum to Commission A18-85
Status: Commission completed

[A18-37] Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V
Status: Commission completed

[A17-56] Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V
Status: Commission completed

[A16-69] Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2019-03-15 Executive summary of dossier assessment (German version) 96 kBPDFdownload file
2019-03-15 Dossier assessment (German version) 989 kBPDFdownload file

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.


At a glance

Accompanying information

Federal Joint Committee (G-BA)

2019-06-06 A G-BA decision was published.

G-BA documents on this decision



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close